Department of Pediatrics, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, I. P. Pavlova 185/6, Olomouc 779 00, Czech Republic.
Department of Pediatrics, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, I. P. Pavlova 185/6, Olomouc 779 00, Czech Republic.
Hepatobiliary Pancreat Dis Int. 2020 Feb;19(1):17-21. doi: 10.1016/j.hbpd.2019.08.004. Epub 2019 Aug 24.
Autoimmune hepatitis (AIH) is a rare progressive liver disease, which manifests as acute hepatitis in 40%-50% of pediatric cases. This refers predominantly to spontaneous exacerbations of previously unrecognized subclinical AIH with laboratory and histological signs of chronic hepatitis, or to acute exacerbations of known chronic disease. Only a few of these patients fulfill criteria for acute liver failure (ALF).
Forty children diagnosed with AIH in our center between 2000 and 2018 were included in this study. All of them fulfilled revised diagnostic criteria of the International Autoimmune Hepatitis Group (IAIHG) for probable or confirmed AIH, and other etiologies of liver diseases were excluded. Patients were divided into two groups: acute AIH (A-AIH) or chronic AIH (C-AIH).
Acute onset of AIH occurred in 19/40 children (48%). Six of them fulfilled the criteria of ALF with coagulopathy and encephalopathy. Five of 6 children with ALF suffered from exacerbation of previously undiagnosed chronic AIH, among which 4 children were histologically confirmed as micronodular cirrhosis. The remaining one patient had fulminant AIH with centrilobular necrosis, but no histological signs of previous chronic liver damage. We observed significantly lower levels of albumin, higher levels of aminotransferases, bilirubin, INR, IgG, higher IAIHG score and more severe histological findings in A-AIH than in C-AIH. No differences in patient age and presence of autoantibodies were observed between A-AIH and C-AIH. All children, including those with ALF and cirrhosis, were treated with corticosteroids, and are alive and achieved AIH remission. Liver transplant was not indicated in any patient.
Rapid and accurate diagnosis of A-AIH may be difficult. However, timely start of immunosuppressive therapy improves prognosis and decreases number of indicated liver transplantations in children with AIH.
自身免疫性肝炎(AIH)是一种罕见的进行性肝脏疾病,在 40%-50%的儿科病例中表现为急性肝炎。这主要是指先前未被识别的亚临床 AIH 的自发性加重,具有慢性肝炎的实验室和组织学征象,或已知慢性疾病的急性加重。只有少数这些患者符合急性肝衰竭(ALF)的标准。
本研究纳入了 2000 年至 2018 年间在我们中心诊断为 AIH 的 40 名儿童。他们均符合国际自身免疫性肝炎组(IAIHG)修订的可能或确诊 AIH 的诊断标准,并排除了其他肝脏疾病的病因。患者分为两组:急性 AIH(A-AIH)或慢性 AIH(C-AIH)。
AIH 急性发作发生在 40 名儿童中的 19 名(48%)。其中 6 名符合 ALF 标准,伴有凝血功能障碍和脑病。6 名 ALF 患儿中有 5 名患有先前未诊断的慢性 AIH 加重,其中 4 名患儿经组织学证实为小结节性肝硬化。其余一名患者患有中-中央坏死性爆发性 AIH,但无先前慢性肝损伤的组织学征象。与 C-AIH 相比,A-AIH 患者的白蛋白水平显著较低,转氨酶、胆红素、INR、IgG 水平较高,IAIHG 评分较高,组织学表现更严重。A-AIH 和 C-AIH 患儿的年龄和自身抗体阳性率无差异。所有患儿均接受皮质类固醇治疗,包括 ALF 和肝硬化患儿,且均存活并实现 AIH 缓解。在任何患儿中均未行肝移植。
快速准确地诊断 A-AIH 可能较为困难。然而,及时开始免疫抑制治疗可改善 AIH 患儿的预后,并减少肝移植的需求。